Kura Oncology (KURA) Tops Q4 EPS by 35c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.22), $0.35 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell